Literature DB >> 1736569

The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia.

Y W Li1, P Whittaker, R A Kloner.   

Abstract

We sought to determine whether short periods of preconditioning ischemia limited infarct size in a model of low coronary collateral flow and whether the effects of preconditioning were transient or long-lasting. Rats underwent 90 minutes of coronary occlusion followed by reperfusion. In one group, the rats were preconditioned by three 3-minute occlusions, each separated by 5 minutes of reperfusion. The size of the myocardial infarcts were smaller in the preconditioned group (24.9 +/- 7.8% of the risk zone developed necrosis) versus the nonpreconditioned group (60.7 +/- 5.3%, p less than 0.01). In addition, the incidence of ventricular arrhythmias was reduced by preconditioning. However, when there was a delay of 1 hour or more between the brief episodes of preconditioning and the longer 90-minute occlusion, the beneficial effects of preconditioning were lost. Thus preconditioning reduced the volume of myocardium infarcted and the incidence of ventricular arrhythmias during a subsequent period of prolonged ischemia; however, these beneficial effects were transient.

Entities:  

Mesh:

Year:  1992        PMID: 1736569     DOI: 10.1016/0002-8703(92)90645-c

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  30 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

3.  Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

Authors:  B Chanyshev; A Shainberg; A Isak; Y Chepurko; E Porat; E Hochhauser
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

4.  Modest intracellular acidification suppresses death signaling in ouabain-treated cells.

Authors:  Olga A Akimova; Dimitri Pchejetski; Pavel Hamet; Sergei N Orlov
Journal:  Pflugers Arch       Date:  2005-07-29       Impact factor: 3.657

5.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

6.  Protection from preconditioning can be reinstated at various reperfusion intervals.

Authors:  E K Iliodromitis; C Papadopoulos; I A Paraskevaidis; Z S Kyriakides; C Flessa; D T Kremastinos
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

7.  Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.

Authors:  V Parikh; M Singh
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

8.  A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits.

Authors:  S Minatoguchi; M Arai; Y Uno; T Kariya; Y Nishida; K Hashimoto; M Kawasaki; G Takemura; T Fujiwara; H Fujiwara
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 9.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

10.  Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.

Authors:  Robert M Mentzer; Joseph Wider; Cynthia N Perry; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-12-23       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.